Peripheral Arterial Disease Market Forecast With Demand and Growth Insights

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Peripheral Arterial Disease Market Projected To Reach By 2030?

The peripheral arterial disease market size has shown significant growth in recent years. This market is expected to increase from $4.74 billion in 2025 to $5.12 billion in 2026, registering a compound annual growth rate (CAGR) of 8.1%. The historical expansion can be attributed to several factors, including the high prevalence of peripheral arterial disease, limited awareness of PAD symptoms, reliance on conventional medications, inadequate access to vascular specialists, and fragmented care delivery systems.

The peripheral arterial disease market is projected for significant expansion over the coming years, reaching a valuation of $7.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This expansion during the forecast period is fueled by several factors, including developments in minimally invasive endovascular techniques, increasing use of drug-eluting devices, the proliferation of hospitals and specialized clinics dedicated to PAD treatment, heightened patient understanding of the benefits of early intervention, and a greater reliance on combined therapeutic approaches that incorporate lifestyle adjustments and medications. Key trends anticipated during this period involve the expanding application of artificial intelligence for prompt diagnosis and risk evaluation, the increasing integration of digital and cloud-based systems for patient monitoring, a heightened emphasis on personalized PAD treatments utilizing genomic data, the greater deployment of IoT-enabled devices for tracking after treatment, and the progressive incorporation of smart manufacturing techniques in the production of PAD devices.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp

What Factors Are Contributing To The Growth Of The Peripheral Arterial Disease Market?

The increasing incidence of diabetes is expected to propel the expansion of the peripheral arterial disease market in the future. Diabetes is defined as a chronic, metabolic illness characterized by elevated blood glucose levels. As the prevalence of diabetes rises, so does the demand for treatments for this condition. The growing prevalence of diabetes is a significant factor in peripheral arterial disease (PAD). Individuals with diabetes are at an increased risk of developing atherosclerosis, which is the most common cause of PAD and necessitates treatment. For instance, in March 2024, reports published by The Office for Health Improvement and Disparities (OHID), a UK-based government agency, showed that between the 15 months ending March 2022 and those ending March 2023, the percentage of people with type 1 diabetes who received eight care processes increased by 22%, while for type 2 diabetes, the increase was 21%. Therefore, the expanding prevalence of diabetes is driving the growth of the peripheral arterial disease market.

How Are Different Segments Classified In The Peripheral Arterial Disease Market Segment Analysis?

The peripheral arterial disease market covered in this report is segmented –

1) By Treatment Type: Devices, Catheters, Drugs, Other Types

2) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

3) By End User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Devices: Stents, Balloons, Atherectomy Devices

2) By Catheters: Drug-Eluting Catheters, Balloon Catheters, Guidewires

3) By Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators

4) By Other Types: Surgical Interventions, Lifestyle Modification Programs, Endovascular Therapy

What Trends Are Shaping The Future Of The Peripheral Arterial Disease Market?

Leading companies in the peripheral arterial disease market are focusing on developing innovative medical devices, such as the intravascular lithotripsy (IVL) catheter, to improve treatment effectiveness, enhance patient outcomes, and shorten recovery periods for individuals with vascular conditions. The intravascular lithotripsy (IVL) catheter is a medical tool utilized to address calcified arterial blockages by emitting controlled shockwaves that break down calcium, thereby helping to reinstate blood flow and improve vessel flexibility during procedures like angioplasty. For instance, in September 2024, Shockwave Medical, Inc., a U.S.-based medical technology company, introduced the Shockwave E8 peripheral IVL catheter. This device is specifically designed to treat peripheral arterial disease by delivering targeted intravascular lithotripsy, which employs sonic waves to disintegrate calcium deposits within arterial walls. This cutting-edge approach aids in restoring blood flow while minimizing harm to surrounding tissues. The catheter’s sophisticated design facilitates simpler navigation through complex vascular anatomy, making it suitable for a broad spectrum of patients.

Who Are The Companies Driving Activity In The Peripheral Arterial Disease Market?

Major companies operating in the peripheral arterial disease market are Johnson and Johnson Limited, Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC

Get The Full Peripheral Arterial Disease Market Report:

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Where Is The Peripheral Arterial Disease Market Primarily Concentrated By Region?

North America was the largest region in the peripheral artery disease market in 2025. The regions covered in the peripheral arterial disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Peripheral Arterial Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Browse Through More Reports Similar to the Global Peripheral Arterial Disease Market 2026, By The Business Research Company

Oral Hygiene Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-hygiene-global-market-report

Oral Care Market Report

https://www.thebusinessresearchcompany.com/report/oral-care-global-market-report

Endodontics Market Report

https://www.thebusinessresearchcompany.com/report/endodontics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795